eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
4/2009
vol. 47
 
Share:
Share:
more
 
 
abstract:
Original paper

Analysis of outpatient administration of methotrexate for rheumatoid arthritis treatment

Maciej Kulig
,
Zofia Malec
,
Witold Tłustochowicz

Reumatologia 2009; 47, 4: 202–206
Online publish date: 2009/10/19
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
A group of 96 persons with rheumatoid arthritis (RA) who received methotrexate at a mean dose of 15 mg per week during their first hospitalization were sent questionnaires with the aim of assessing their GP’s attitude towards management of RA. Forty-eight replies were obtained. The results were: 44 patients continued treatment, 4 discontinued therapy for various reasons. No serious adverse effects were observed. Although most of the patients exhibited signs of heightened disease activity, the dosage was not modified in half of the group studied, 13 patients had the dosage reduced to the dosage level which is regarded as ineffective, only 2 had the dosage increased. None of the patients was administered the recommended methotrexate dose of 25 mg per week. Ineffectiveness of small doses of methotrexate resulted in prolonged treatment with corticosteroids. To summarize, the authors emphasize the need for the promotion of methotrexate treatment standards among physicians and their patients.
keywords:

rheumatoid arthritis, methotrexate, ambulatory treatment




Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe